, , ,

<<


 >>  ()
Pages:     | 1 |   ...   | 7 | 8 ||

- ...

-- [ 9 ] --

262. Cornelissen J.J, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM, et al. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leuke mia in young and middle-aged adults: benefits for whom? Blood [Internet]. 2007 May [cited 2011 Jan 11] ;

109 (9): 3658 66. Available from:http:// bloodjournal.hematology library.org/cgi/reprint/109/9/3658 PubMed: PM 263. Colombo M.B., Haworth S.E., Poli F. et al. Luminex technology for anti-HLA an tibody screening: evaluation of performance and of impact on laboratory routine // Cy tometry B Clin Cytom. 2007. Vol.72(6). P. 465 71.

264. Craven .., Ward . Transfusion of fetal cord blood cells: An improved of hematopoietic stem cells transplantation? // J. Reprod. Immenol. 1999. Vol.42. P.

59 77.

265. Cutler DM, McClellan M. Is technological change in medicine worth it?// Health Affairs. 2001. Vol. 20. P. 11 29.

266. Deeg H.J., Socie G. Malignancies after hematopoietic stem cells trans-platation:

Many questions, some answers // Blood. 1998. Vol.91. P. 1833 1844.

267. Deming W.E. Out of the Crisis. MIT Press, 1986.

268. Deming W.E. The New Economics for Industry, Government, Education.// 2nd.

MIT Press, 2000.

269. Deming W.E. Some Theory of Sampling. // Dover Publications, 1986.

270. Denning-Kendall P., Donaldson C., Nicol A. et al. Optimal processing of human umbilical cord blood for clinical banking // Exp Hematol. 1996. Vol.24(12). P.

1394 1401.

271. Diagnostic Related Groups (DRG) an Instrument fur Pazient bezogene Betriebs tenerung und Finanzierung in der USA // Kranken Haus Umsch. 1986. Bol. 6. P.

656 660.

272. Dunbar SA. Applications of Luminex xMAP technology for rapid, high throughput multiplexed nucleic acid detection. // Clin Chim Acta. 2006. Jan;

363(1 2): 71 82. Epub 2005 Aug 15.

273. Donabedian A. Criteria, norms and standards of quality: what do they mean? / A.

Donabedian//Amer. J. Publ. Hlth. 1981. V. 71.

274. Donabedian A. The quality of care. How can it be assessed? /A. Donabedian // JAMA. 1988. V. 260, N 12. P. 1743 1748.

275. Donabedian A. The quality of medical care methods for issuing andmonitoring the quality of care research and for quality assurance programs /A. Donabedian // Sci ence. 1978. 20. P. 856 864.

276. DRG and the Prospective Patient System: a Guide for Physicians. Chicago, American Medical Associaion, 1993. 40 p.

277. Donaldson C., Armitage W.J., Denning-Kendall P.A., et al. Optimal cryopreserva tion of human umbilical cord blood // Bone Marrow Transplant. 1996. Vol.18(4). P. 725 773.

278. Dupont B. Immunology of hematopoietic stem cell transplantation: a brief review of its history // Immunological Reviews. 1997. Vol.157. P. 5 12.

279. Dushez P., Dazey B., Douay L., et al. An efficient large-scale thawing procedure + for cord blood cells destined for selection and ex vivo expansion of CD34 cells // Jour nal of Hematotherapy and Stem Cell Research. 2003. Vol.12. P. 587 589.

280. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor hae mopoietic stem-cell transplantation in adults with acute leukemia: a retrospective analy sis // Lancet. 2010. Vol.11. P. 653 60.

281. Eichler H., Kern S., Beck C., et al. Engraftment capacity of umbilical cord blood cells processed by either whole blood preparation and filtration // Stem Cells. 2003. Vol.21. P. 208 216.

282. Esato K et al. Neovascularization induced by autologous bone marrow cell im plantation in peripheral arterial disease // Cell Transplant. 2002. V.11;

8. P. 747 752.

283. Felter R. Diagnostic Related Groups the product of Hospital //Clin. Research. 1994. V. 321. P. 336 340.

284. Ferrel B. Pain and quality assessment improvement /B. Ferrel, M. Whedon, B.

Rollins //Journal of Nursing of Care Quality. Aspen Publishers, Inc. 1995. V. 9, N 3.

P. 69 85.

285. Fernandez C.V., Gordon K., Van den Hof M. et al. Knowledge and attitudes of pregnant women with regard to collection, testing and banking of cord blood stem cells // CMAJ. 2003. Vol.168. P. 695.

286. Feigenbaum A.V. Quality control: principles, practice and administration;

an in dustrial management tool for improving product quality and design and for reducing operating costs and losses. // McGraw-Hill industrial organization and management se ries, New York, McGraw-Hill. 1980.

287. Feigenbaum A.V. Total Quality Control/// McGraw-Hill. 288. Feigenbaum A.V/ The power of management capital : utilizing the new drivers of innovation, profitability, and growth in a demanding global economy/// McGraw-Hill. 2003.

289. Feigenbaum A.V. The power of management innovation : 24 keys for sustaining and accelerating business growth and profitability/// McGraw-Hill mighty manager handbooks., McGraw-Hill. 2009.

290. FIPS 183 USA Integration definition for function modeling (IDEF0), 2001.

291. Garritsen H., Louwen F. et al. Autologous red cells derived from cord blood: col lection, preparation, storage and quality controls with optimal additive storage medium // Transfusion Medicine. 2003. Vol.13. P. 303 10.

292. Gay E. Regulation retrenchment the DRG experience: problems fromchanging reimbursement practice /E. Gay, J. Kronenfeld //Soc. Sci. med. 1990. Vol. 31, N 10.

P. 1103 1118.

293. Glasser W. Paying the hospital. San Francisco, 1987. 340 p.

294. Gluckman E., Rocha V., Chastang C. Cord blood banking and transplant in Eu rope // Eurocord. Vox Sang. 1998. Vol.74. P. 95 101.

295. Gluckman E., Broxmeyer H.E., Auerbach A.D. et al. Hematopoietic reconstitu tion in a patient with Fanconi's anemia by means of umbilical cord from an HLA iden tical sibling // N. Engl. J. Med. 1989. Vol. 321. P. 1184 1178.

296. Gluckman E., Rocha V., Boyer-Chammard A. et al. Jut come of cord blood trans plantation from related and unrelated donors // N. Engl. J. Med. 1997. Vol. 337. P.

373 381.

297. Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectivness in health and medicine // New York, NY: Oxford University Press.-1996.

298. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolida tion/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood [Internet]. 2008 Feb 15 [cited 2011 Jan 11];

111(4):1827-33. Available from: http:// bloodjour nal.hematologylibrary.org/cgi/reprint/111/4/1827 PubMed: PM 299. Grewal S.S., Barker J.N., Davies S.M., Wagner J.E. Unrelated donor hematopoi etic cell transplantation: marrow or umbilical cord? // Blood. 2003. Vol.101 11.

P. 4233 4244.

300. Greenberg D.S. The Clintons present their health plan / D.S. Greenberg // Lancet.

1993. Vol. 342. N 6876. P. 503 506.

301. Gunter T. D., Terry N.P. The Emergence of National Electronic Health Record Architectures in the United States and Australia: Models, Costs, and Questions // Jour nal of Medical Internet Research. 2005 V 7.

302. Hackel E., Mallory D. Theoretical Aspects of HLA. American Assotiation of Blood Banks. 1982 Arlington. VA. pp. 1 141.

303. Haley N.R., Sugarmann J., Harvath L. Conference report: Ethical issues in cord blood banking // Transfusion. 1998. Vol.38. P. 867 873.

304. Han M, Tan YQ, Zhang Y, Tsai J, Vorhaben R, Moraes JR, Moraes ME, Stastny P.

Multiplex single nucleotide extension: a robust and high throughput method for HLA-A locus typing // HUMAN IMMUNOLOGY. 2003. - 64(12):1111- 305. Hansen J.A. Development of registries of HLA-typed volunteer marrow donors. // Tissue Antigens 1996. Vol.47 P.460-463.

306. Hansen J.A., PetersdorfE., Martin P.J., Anasetty C. Hematopoietic stem cells transplants from unrelated donor// Immunol. Rev. 1997. Vol.157. P. 141 51.

307. Harris D.T. Experience in autologous and allogeneic cord blood banking // J.

Hematother. 1996. Vol.5. P. 123 128.

308. Haylock D.N., Simmons P.J., Juttner .A. The biology and clinical used of blood stem cells // Blood. 1997. Vol.89. P. 2233 2258.

309. Hans-Erik Eriksson, Magnus Penker Business Modeling with UML: Business Patterns at work. Wiley Computer Publishing, 2000.

310. Harrington H. James. Total Improvement Management, McGraw-Hill, NewYork, 1995.

311. Harrington H. James. The Complete Benchmarking Implementation Guide, McGraw-Hill, New York., 1996.

312. Harter D. E., Slaughter S. A. Process Maturity and Software Quality: A Field Study // Proceedings of the Twenty First International Conference on Information Sys tems. December. 2000.

313. Henry F. Medical Group Clinical Practice Improvement Process. // http://hfhscce.org/guiderprn.htm, 1998.

314. Hirata K, et al. Autologous bone marrow cell implantation as therapeutic angio genesis for ischemic hindlimb in diabetic rat model //Am J Physiol Heart Circ Physiol. 2003. V. 284. P. H66 70.

315. Higashi Y, et al. Autologous bone-marrow mononuclear cell implantation im proves endothelium-dependent vasodilation in patients with limb ischemia // Circ. 2004. V.109. P. 1215 1218.

316. Horner M. Leadership theory: past, present and future // Team Professional Man agement. 1999. Vol. 3, N 4. P. 270 287.

317. Hoffman R., Rozler E., Chute J. et al. Ex vivo expansion of human hematopoietic stem cells: Implications for modern blood bank // Vox sang 1998;

74 (suppl.): 259 264.

318. Howard D, Maiers M, Kollman C, Logan B, Gragert L, Setterbolm M. A cost benefit analysis of increasing cord blood inventory levels // Cord blood// Washington. 2005. P. 221 241.

319. Hosono S., Mugishima H., Nakano Y. et al. Autologous cord blood transfusion in an infant with a huge sacrococcygeal teratoma.// J. Perinat. Med. 2004. Vol.32. P.

187 189.

320. Hunt C.J., Armitage S.E., Pegg D.E. Cryopreservation of umbilical cord blood: 2.

+ Tolerance of CD34 cells to multimolar dymethyl sulphoxide and effect of cooling rate on recovery after freezing and thawing // Cryobiology. 2003. Vol.46. P. 76 87.

321. Huang PP, et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities // Thromb Haemost. 2004. V.91. P. 606 609.

322. Iba O, et al. Angiogenesis is by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs // Circ. 2002. V.106. P. 2019 2025.

323. Itoh Y., Mizuki N., Shimada T. et al. High-throughput DNA typing of HLA-A, B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. // Immunogenetics. 2005. Vol.57(10) P. 717 29.

324. International standard ISO 9001/Third edition. 2000. ISO 8402:1994. Quality Management and Quality Assurance Vocabulary.

325. Jin N.R., Hill R.S., Peterson F.B. et al. Marrow harvesting for autologous marrow transplantation // Exp. Hematol. 1985. Vol.13. P. 879 884.

326. Juran J. M. Juran on leadership for quality. An executive handbook /J.M. Juran. New York,: Free Press, 1989. 376 p.

327. Juran J.M. Strategies for world class quality /J.M. Juran // Quality Progress. 1991. Vol. 24, N3. P. 81.

328. Juran J.M. Strategic Quality Management. Juran's Quality Control Handbook, chapter 6. McGra-Hill, Inc, 1992.

329. Kamiishi T., Itoh.Y, Meguro A. et al. Four-digit allele genotyping of HLA-A and HLA-B genes in Japanese patients with Behet's disease (BD) by a PCR-SSOP-luminex method and stratification analysis according to each major symptom of BD// Nippon Ganka Gakkai Zasshi. 2008. Vol.112(5). P. 451 8.

330. Keethesan N., Whiteman C., Malczewski A., et al. Effect of cryopreservation on the immunogenicity of umbilical cord blood cells // Transfusion and Apheresis Science.

2004. Vol.30. P. 47 54.

331. Kinmond S., Aitchison T.C., Holland B.M. et al. Umbilical cord clamping and preterm infants: A randomized trail. // Br. Med. J. 1993. Vol.306. P. 172 175.

332. Kondo Y. Participation and Leadership /Kondo Yoshio //Proceedings44th EOQ Congress. Budapest, 2000. Vol. 2. P. 110 117.

333. Kollman C, Esteban A, Baitty T, Beatty P, Chakraborty T, Christiansen C, Hartz man RJ, Hurley CK, Milford E, Nyman J, Smith T, Switzer G, Wada R, Setterholm M.

Assessment of optimal size and composition of the U.S. national registry of hematopoi etic stem cell donors // Transplantation. 2004. Vol. 78, 1. P. 89 95.

334. Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, et al. Al logeneic stem cell transplantation for acute myeloid leukemia in first complete remis sion: systematic review and meta-analysis of prospective clinical trials. JAMA [Inter net]. 2009 Jun 10 [cited 2011 Jan 11];

301(22):2349-61. Available from: http://jama.ama assn.org/content/301/22/2349.full.pdf+html PubMed: PM 335. Kudo FA, et al. Autologous transplantation of peripheral blood endothelial pro genitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ische mia // Int Angiol. 2003. V. 22. P. 344 348.

336. Laroche V., McKena D., Moroff G., et al. To wash or not to wash?: an analysis of standard umbilical cord blood processing methods // Abstracts of ISCT conference, Dublin, 2004.

337. Leitman S.T., Read E.J. Hematopoietic progenitor cells. Semin. // Hematol. 1996. Vol.33. P. 341 358.

338. Limaye L.S., Kale V.P. Cryopreservation of human hematopoietic cells with memrane stabilizers and bioantioxidants as additives in the conventional freezing medi um// Journal of Hematotherapy and Stem Cell Research. 2001. Vol.10(5). P. 709 718.

339. Little A.M. Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection // Curr. Opin. Hematol. 1998 Vol.15. P.419 42.

340. Locatelli R, Rocha V., Chastang C. et al. Factors associated with out come after cord blood transplantation in children with acute leukemia // Blood. 1999. Vol.93. P. 3662 3679.

341. Mavroiidis D., Read E., Cottier-Fox M. et al. CD34+cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplantation for hematologic malignancies // Blood. 1996. Vol. 88. P. 3223 3229.

342. Matsubara H.Therapeutic angiogenesis for patients with critical limbis chemiaus ing autologous bone marrow cell transplantation //NipponNaikaGakkaiZasshi (japan) 2003. V.10. 92;

5 P.877 343. Matsui K, et al. Therapeutic angiogenesis by transplantation of autologous bone marrow and peripheral blood mononuclear cells in patients with peripheral arterial dis ease //Int J Angiol. 2003. V. 12;

3 P. 155 344. Mc Cullough J., Clay M.E. et al. Proposed policies and procedures for the estab lishment of a cord blood bank // Blood Cells. 1994. Vol.20. P. 609 629.

345. McCarthy DRG" s five years later. //New Engl. Med. J. 1998. V. 318. P.

1638 1686.

Meagher R.S., Herzig R.H. Techniques of harvesting and cryopreservation of 346.

stem cells // Hematol. Oncol. Clin. N.A.-1993.-Vol.7.-P.501-533.

347. Murohara T, et al. Transplanted cord bloodderived endothelial precursor cells augment postnatal neovascularization //J Clin Invest. 2000. Vol. 105. P. 1527 1536.

348. Newton I., Charbord P., Schaal J.P., Herve P. Toward cord blood banking: densi ty-separation and cryopreservation of cord blood progenitors // Exp Hematol. 1993. Vol.21(5). P. 671 674.

349. Nelson R. Computerized Patient Records Improve PracticeEfficiency and Patient Care //Health care financial management. 1998. Vol. 4. P. 86 87.

350. Netcord / www/netcord.org 351. Neuhauser D. Clinical CQL A book of readings /D. Neuhauser et al. //Joint Commission on Accreditation of Healthcare Organizations, Department of Publications, 1995 234 352. NICE, Guide to the Methods of Technology Appraisal, April 2004 (Ref N0515) paragraphs 6.2.6.10 353. Oh W., Cairo M.S., Desposito F., et al. Cord blood banking for potentional future transplantation: subject review.//Pediatrics. 1999. Vol.104. 1. P. 116 118.

354. Ohwada C., et al. Second cord blood transplantation (CBT) with reduced intensity conditioning for graft failure after the first CBT for AML // Bone Marrow Transplant. 2004. Vol. 34. T.11. P. 999 1000.

355. Paxson C.L Collection and use of autologous fetal blood // Am. J. Obstet. Gyne col. 1979. Vol. 134. P.708 10.

356. Petita A. The transition to medication system performance indicators Topicsin Hospital Pharmacy Management /A. Petita et al. //Aspen Publishers, Inc. 1995. V.

14. T.4. P. 20 26.

357. Pesce M, et al. Myoendothelial differentiation of human umbilical cord blood derived stem cells in ischemic limb tissues //Circ Res. 2003. Vol. 93. P. 51.

358. Querol S., Azqueta C., Garsia J. Effect of red blood cell content on progenitor function after Cryopreservation of cord blood buffy-coat products // Abstracts of EBMT Conference, Montreux, 2002.

359. Regidor C., Posada M., Monteagudo D., et al. Umbilical cord blood banking for unrelated transplantation: evaluation of cell separation and storage methods // Exp He matol. 1999. Vol. 27(2). P. 380 385.

360. Robert B., Rutherford J., Dennis B. et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version // J. vascular surg. 1997. V.26. P. 517 38.

361. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia // Blood. 2001. Vol.97. P. 2962 2971.

362. Rocha V, et al. Umbilical cord blood transplantation // Curr Opin Hematol. 2004. Vol.11. T.6. P. 375 385.

363. Rowley S.D., Anderson G.L. Effect of exposure without cryopreservation on hematopoietic progenitor cells // Bone Marrow Transplantation. 1993. Vol.11. P.

389 393.

364. Rowling P.A. Summery current use outcome of blood and marrow transplantation // Milwan Kee, WI: AKMTR Newsletter. 1996.


365. Rubinstein P., Carrier C, Ccarada van A. et al. Out comes among 562 recipients of placental-blood transplants from unrelated donors // N. Engl. J. Med. 1998. Vol.339. P. 1565 1577.

366. Rubinstein P., Dobrila L., Rosenfield R.E., Adamson J.W. Processing and cryo preservation of placental/umbilical blood for unrelated bone marrow reconstitution// Proc. Natl. Acad. Sci. USA. 1995. Vol.92. P. 10119 10122.

367. Rubinstein P., Rosenfield R.E., Adamson J. W., Stevens C.E. Stored placental blood for unrelated bone marrow reconstitution // Blood. 1993. Vol.81. P.1679 1690.

368. Saine D. Communication strategies to improve drug use evaluation Topics inHos pital Pharmacy Management /D. Saine //Aspen Publishers, hie. 1995. V. 14. T.4. P. 48 54.

369. Schepers K.G., Davis J.M., Rowley S.D. Incidence of bacterial contamination of bone marrow graft // Prog. Clin. Biol. Res. 1992. Vol. 377. P. 379 384.

370. Sharp T.G., Sachs D.H., Matthews J.G. et al. Harvest of human bone marrow di rectal from bone // J. Immunol. Methods. 1984. Vol.69. P. 187 195.

371. Shintani S, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circ 2001;

103: 897 Singhal S., Mehta J. Reimmunization after blood or marrow stem cells transplantation // BMT. 1999. V. 23. P. 637 646.

372. Smith D.M., Baker J.E., Gardner W.B.et al. HLA class I null alleles and new al leles affect unrelated bone marrow donor searches. // Tissue Antigens. 2005. Vol.

66(2). P. 93 98.

373. Strauss R.G. Red blood cells transfusion in the neonate// Clin. Perinatol. 1995. Vol.22. P.641 55.

374. Stroncek D.F., Holland P. V., Bartch G. et al. Experiences of the first 493 unrelat ed marrow donors in the NMDP // Blood. 1993. Vol.81. P. 1940 1946.

375. Stroneek D.L., Clay M.E., Smith J. et al. Composition of peripheral blood pro genitor cell components collected from healthy donors. // Transfusion. 1997. Vol.

37. P.411 417.

376. TakahashiS, OoiJ, TomonariA, KonumaT, TsukadaN, Oiwa-MonnaM, et al.Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regi men // Blood. 2007. Vol.109. P.13221330.

377. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial//Lancet. 2002. V. 360. P. 427 435.

378. Teiji O. Treatment for limb ulcer with severe ischemia: therapeutic angiogenesis by autologous transplantation of bone-marrow//Wound Repair Regen. 2004. Vol. 12.

T.1: A5 (abstract).

379. Theunissen K., Boogaerts M., Lauweryns L., et al. Fully automated and reproduc ible cord blood processing using the Biosafe Sepax and Coolmix Devices // Abstracts of ASH Conference, San Diego, 2003.

380. Thoma S.J., Bosse R., Schultz J., et al. Stem cell processing with an automated system // Abstracts of EBMT Conference, Montreux, 2002.

381. Tichelli A., Gubelmann A., Schmolck C., et al. Automated volume reduction of cord blood using the Sepax system // Materials of symposium on PBSC transplantation, Mulhouse. 1999.

382. Toropovskiy A. Distribution of HLA alleles in population of Samara region / A.

Toropovskiy, O. Tyumina et al. // Tissue antigens. 2009. Vol. 73/ T.5. P. 464.

383. Turner M.L., McClelland D.B., Franklin I.M. Heamopoietic progenitor cell har vesting processing and storage: Global regulation to en sure the quality of products for patients // Br. J. Haematol. 1997. Vol.99. P. 715 718.


384. Vey N, Thomas X, Picard C, Kovascovicz T, Charin C, Cayuela JM, et al. Al logeneic stem cell transplantation improves the outcome of adults with t(1;

19)/E2A PBX1 and t(4;

11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia. 2006 Dec;

20(12):2155-61.

PubMed: PM 385. Yasutake M., Sumita M., Terashima S., et al. Stem cell collection filter system for human placental/umbilical cord blood processing // Vox Sang. 2001. Vol.80(2). P.

101 105.

386. Yanada M, Matsuo K, Suzuki T, Naoe T. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer [Internet]. Jun 15 [cited 2011 Jan 11];

106(12):2657-63. Available from:

http://onlinelibrary.wiley.com/doi/10.1002/cncr.21932/pdf PubMed: PM 387. Yang C, et al. Transplantation of cord blood endothelial progenitor cells amelio rates limb ischemia//Zhonghua Yi Xue Za Zhi. 2003. Vol. 83, (16) P. 1437 1441.

388. Volchkov S. Defining the best source of human multipotential mesenchymal stromal cells (MSC) / S. Volchkov, P. Boriskin, O. Tyumina. // Cellular Therapy and Transplantation 2010. Vol. 3. T.9. P.127.

389. Wagner J.A., Kernan N.A., Steinbuch et al. Allogeneic sibling umbilical cord blood transplantation in children with malignant and non-malignant disease // Lancet. 1990. Vol. 346. P. 214 249.

390. Wagner J.E., Kernan N.A., Steinbuch M. et al. Allogenic sibling umbilical cord blood transplantation in children with malignant and non-malignant disease // Lancet. 1995. Vol. 346. P. 214 219.

391. Wagner JE, et al. Transplantation of unrelated donor umbilical cord blood in patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival // Blood. 2002. Vol. 100.

P. 1611 1618.

392. Watt S.M., Contreras M. Stem cell medicine: Umbilical cord blood and its stem cell potential // Seminars in fetal and neonatal medicine. 2005. Vol.10. P. 209 220.

393. Wolff S. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection of relapse after allogenic transplantation // Bone Marrow Trans plant. 2002. Vol.29. P. 545 552.

394. Woods E., Liu J., Pollok K., et al. A theoretically optimized method for cord blood stem cell cryopreservation // Journal of Hematotherapy and Stem Cell Research. 2001. Vol.12(3). P. 341 350.

395. Xiao H.H., Hua T.C., Li J., et al. Freeze-drying of mononuclear cells and whole blood of human cord blood // Cryoletters. 2004. Vol.25(2). P. 111 120.

!

.

. . .: ( ) : 1.1 18-25 ;

1.2. 25-30 ;

1.3. 30-35 ;

1.4. 35-40 ;

1.5. 40-50 ;

1.

1.6.50 :2.1- ;

2.2. 2.

:3.1 ;

3.2 -;

3.3 3.

: 4.1 10 . . 4.2 10-30 . . 4.3 30 . .

4.

: 5.1 5.2 5.3 5.

: 6.1 ;

6.2 6.

, . .

7. ? (1 , 1 3 , 5 /).

8. ( 1 2 3 4 ) 9. ( 1 2 3 4 ) 10. (, 1 2 3 4 , ) 11. (5 ;

4 10 ;

3 1 2 3 4 ;

2 40 ;

1 - 1 ) 12. (, , , , )? 1 2 3 4 13. , , 1 2 3 4 ?

14. , , :

a. - 1 2 3 4 b. - (, ) 1 2 3 4 15. 1 . ? (1 , 5 ).

16. , 1 2 3 4 ?

17. 1 ? (1 , 5 ) 18. , 1 2 3 4 19. ? 1- , 2 - , , 3 , 4- - 1 2 3 4 , 5- , , 20. ( ), ( , , 1 ) , , ? (1 , 5 ) 21. -, 1 2 3 4 22. ?

_ _ 23. ?

;

;

;

24. ?

_ _ 25. 1. ( 5 ) .

2. ( 5 ) ,

( 5 ) / 1 2 , 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Pages:     | 1 |   ...   | 7 | 8 ||
 
 >>  ()





 
<<     |    
2013 www.libed.ru - -

, .
, , , , 1-2 .